المؤلفون: Robert Z. Orlowski, Marta Polo Zarzuela, Clarissa M. Uhlar, Joan Bladé, Manjula Reddy, Jesús F. San-Miguel, Xiang Qin, Helgi van de Velde, Hong Xie, Sebastian Grosicki, Tadeusz Robak, Maria-Victoria Mateos, Jacob P. Laubach, Tom Puchalski, Chang-Ki Min, Sripada V.S.S Prasad, Andrew Spencer, Yeow Tee Goh, Frédéric Maloisel, Ofer Shpilberg, Antonio Palumbo

المصدر: Blood. 123(26)

مصطلحات موضوعية: Melphalan, Male, medicine.medical_specialty, Clinical Trials and Observations, Immunology, Biochemistry, Gastroenterology, Siltuximab, Disease-Free Survival, Bortezomib, chemistry.chemical_compound, Maintenance therapy, Prednisone, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Survival rate, Multiple myeloma, Aged, Aged, 80 and over, business.industry, Interleukin-6, Antibodies, Monoclonal, Cell Biology, Hematology, Middle Aged, medicine.disease, Boronic Acids, Surgery, Immunoglobulin A, Survival Rate, chemistry, Pyrazines, Anti-IL-6, Female, Chromosome Deletion, business, Multiple Myeloma, medicine.drug, Chromosomes, Human, Pair 17, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2c9de2d12852ba27ced881402cc3b99
https://pubmed.ncbi.nlm.nih.gov/24833354